By purchasing our forecast for MEDTRONIC PLC (MDT) for the period of 6 Days, you can gain valuable insights into the changes in value and dynamics of MDT. Our forecast will provide you with information on how the cost of MDT will change in December 2024, January 2025, February 2025, March 2025, and April 2025. This information is essential for making informed investment decisions and diversifying your portfolio. Stay updated with our website for the release of new forecasts, ensuring that you are aware of the entire investment period. Take advantage of our forecast to optimize your earning potential.
May 1, 2025Medtronic Receives FDA Approval for Groundbreaking Defibrillation Lead ~2 min.Medtronic PLC, a global leader in medical technology, has recently received FDA approval for its revolutionary 4.7F defibrillation lead, the smallest-diameter lumenless lead available on the market....
March 22, 2025Innovative Medical Device Company, Medtronic PLC, Surges in Popularity Among Investors ~2 min.Medtronic PLC (MDT) is gaining significant attention from investors due to its groundbreaking medical technology and long-term growth potential....
March 21, 2025Medtronic plc MDT: Experts Recommend Buying Stocks for Long-Term Investment ~1 min.According to the renowned financial experts at Stocks Prognosis, Medtronic plc (MDT) is one of the best European stocks to buy for long-term investment....
March 20, 2025Medtronic plc: A Promising Investment Opportunity for Investors ~2 min.Medtronic plc (MDT) is attracting the attention of investors as it emerges as one of the best European stocks to buy, according to billionaires....
March 18, 2025Medtronic PLC takes steps to strengthen their position in the cardiovascular therapies market ~1 min.Medtronic PLC, a leading medical technology company, is focused on bolstering its moat in the cardiovascular therapies market with the introduction of novel treatments....
March 17, 2025Medtronic PLC Reports Positive Trial Data on Evolut TAVR ~2 min.Medtronic PLC, a leading medical technology company, has announced positive trial data for its Evolut Transcatheter Aortic Valve Replacement (TAVR) system....
March 16, 2025Medtronic plc MDT Continues to Demonstrate Superior Valve Performance in Small Annulus Patients ~1 min.Medtronic plc's Evolut TAVR system has proven to be a game-changer in the field of transcatheter aortic valve replacement (TAVR) for small annulus patients....
March 15, 2025Positive Trial Data on Evolut TAVR Likely to Support MDT Stock ~1 min.Medical technology company Medtronic plc (MDT) is expected to receive a boost in its stock performance following positive trial data on its Evolut TAVR system....
March 14, 2025Medtronic plc's Evolut TAVR System Demonstrates Superior Valve Performance in Small Annulus Patients ~2 min.Medtronic plc (MDT) has recently released two-year data from its SMART Trial, showcasing the exceptional valve performance of its Evolut transcatheter aortic valve replacement (TAVR) system in patients with small annulus. The trial results revealed that the Evolut TAVR system offered a significant improvement in valve performance, with a 5x better outcome compared to conventional treatment options...
February 28, 2025Medtronic plc Explores Global Options to Escape Trump Tariffs ~2 min.Medtronic, a leading medical technology company, is actively looking for ways to navigate the current economic landscape and avoid the impact of Trump tariffs....
February 27, 2025Medtronic plc MDT: Revolutionary Adaptive Brain Stimulation System for Parkinson's Disease Receives FDA Approval ~1 min.Medtronic, a leader in medical technology, has recently earned the U.S. FDA's approval for its groundbreaking adaptive deep brain stimulation system for individuals with Parkinson's disease....
February 26, 2025MDT Medtronic PLC's Q3 2025 Earnings Call Highlights: Strong Growth in Cardiac and Neuromodulation Segments ~2 min.Medtronic PLC, a global leader in medical technology, recently announced its Q3 2025 earnings call highlights, showcasing strong growth in its cardiac and neuromodulation segments....
February 25, 2025Medtronic reports strong growth in cardiac and neuromodulation segments in Q3 2025 ~2 min.Medtronic PLC, a global leader in medical technology, has announced its financial results for the third quarter of fiscal year 2025....
February 19, 2025Medtronic plc: Revolutionizing Patient Care with Healthcare IT ~2 min.Medtronic plc, a global medical technology company, is making significant strides in revolutionizing patient care through its innovative healthcare IT solutions....
February 14, 2025Medtronic plc MDT: A Leading Medical Device Company ~2 min.Medtronic plc (MDT) is a global leader in medical technology, offering innovative solutions for healthcare professionals and patients worldwide....
February 13, 2025Medtronic MDT Stock Moves -0.89: What You Should Know ~1 min.Medtronic plc, a leading medical device company, recently experienced a stock movement of -0.89. This news highlights the importance of staying updated on the latest developments in the stock market....
February 11, 2025Medtronic plc MDT: A Promising Investment Opportunity in the Foreign Dividend Stocks Market ~2 min.Medtronic plc, a global leader in medical technology, presents a promising investment opportunity in the foreign dividend stocks market....
February 9, 2025Medtronic Plc's Stock Faces Contradicting Trends: Strong Performance vs Weak Fundamentals ~2 min.Medtronic Plc (NYSE: MDT) has been experiencing a strong performance in the stock market, but its fundamentals reflect a different story....
February 8, 2025Medtronic plc MDT: Among the Best Dividend Stocks for Long-Term Investors ~2 min.In the world of medical technology, Medtronic plc (NYSE:MDT) has established itself as a leader in innovation and profitability....
February 7, 2025Medtronic plc MDT: Among the Best Dividend Stocks to Buy and Hold ~2 min.Medtronic plc (NYSE:MDT) is emerging as one of the best dividend stocks to buy and hold for long-term investors....
| Stock ticker: | MDT |
| Name: | MEDTRONIC PLC |
| Sector: | Healthcare |
| Investing Risk: | MEDIUM |
| Forecast length: | 6 days |
| Accuracy: | 31.11 % |
| Average profit per target: | 4.54 % |
